NEW YORK GENOME CENTER INC: Form 990, tax year 2018
View the entire original 990 at ProPublica ↗
- Organization
- NEW YORK GENOME CENTER INC (EIN 80-0631734)
- Tax period
- 2018-01-01 to 2018-12-31
- Filed
- 2019-11-12
- IRS object ID
- 201913169349306091
- Schema version
- 2018v3.1
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule C
- Schedule D
- Schedule F
- Schedule G
- Schedule I
- Schedule J
- Schedule O
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2019-11-12T16:42:22-06:00 | ReturnTs |
| Tax Period End | 2018-12-31 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | KPMG LLP | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 345 Park Avenue | AddressLine1Txt |
| City | New York | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 101540102 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2018-01-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 800631734 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | NEW YORK GENOME CENTER INC | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| In Care Of | % NANCY KONG | InCareOfNm |
| Business Name Control | NEWY | BusinessNameControlTxt |
| Phone | 6469777000 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 101 AVENUE OF THE AMERICAS Suite 7T | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10013 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | ANA BASTIANI-POSNER | PersonNm |
| Person Title | SR. VP, FIN & ADMIN | PersonTitleTxt |
| Phone | 6469777000 | PhoneNum |
| Signature | 2019-11-11 | SignatureDt |
| Discuss With Paid Preparer | Yes (true) | DiscussWithPaidPreparerInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | DEVIN L DUNCAN | PreparerPersonNm |
| PTIN | P01249521 | PTIN |
| Phone | 2127589700 | PhoneNum |
| Preparation | 2019-11-08 | PreparationDt |
Filing Security Information FilingSecurityInformation
IP Address IPAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| I Pv4 Address | 167.68.102.5 | IPv4AddressTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Federal Original Submission Id | 13407320193165000055 | FederalOriginalSubmissionId |
| Federal Original Submission Id | 2019-11-12 | FederalOriginalSubmissionIdDt |
| Filing License Type | P | FilingLicenseTypeCd |
| At Submission Creation Device Id | E5B8B957A2AE6FBC7C2F9BFE70C193B66AC8EB5E | AtSubmissionCreationDeviceId |
| At Submission Filing Device Id | B09A8F7452AAEB109EF01FBCB66ABFE0CB6B8889 | AtSubmissionFilingDeviceId |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2018 | TaxYr |
| Build TS | 2020-03-31 21:24:44Z | BuildTS |
Form 990 IRS990
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | CHERYL A MOORE | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 101 AVENUE OF THE AMERICAS | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10013 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $130,390,413 | GrossReceiptsAmt |
| Group Return For Affiliates | false | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | www.nygenome.org | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 2010 | FormationYr |
| Legal Domicile State | DE | LegalDomicileStateCd |
| Activity Or Mission | NYGC IS AN INDEPENDENT, NONPROFIT ACADEMIC RESEARCH INSTITUTION DEDICATED TO GENOMIC DISCOVERY TO ADVANCE HUMAN HEALTH. | ActivityOrMissionDesc |
| Voting Members Governing Body | 25 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 23 | VotingMembersIndependentCnt |
| Total Employee | 222 | TotalEmployeeCnt |
| Total Volunteers | 24 | TotalVolunteersCnt |
| Total Gross UBI | $4,762,195 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | -$1,928,104 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $70,723,214 | PYContributionsGrantsAmt |
| CY Contributions Grants | $115,038,771 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $23,716,598 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $13,156,320 | CYProgramServiceRevenueAmt |
| PY Investment Income | $88,421 | PYInvestmentIncomeAmt |
| CY Investment Income | -$14,680 | CYInvestmentIncomeAmt |
| PY Other Revenue | $95,299 | PYOtherRevenueAmt |
| CY Other Revenue | $268,539 | CYOtherRevenueAmt |
| PY Total Revenue | $94,623,532 | PYTotalRevenueAmt |
| CY Total Revenue | $128,448,950 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $991,540 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $1,300,475 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $30,157,920 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $28,154,290 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $140,000 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $58,590 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $1,140,239 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $60,996,415 | PYOtherExpensesAmt |
| CY Other Expenses | $55,044,830 | CYOtherExpensesAmt |
| PY Total Expenses | $92,285,875 | PYTotalExpensesAmt |
| CY Total Expenses | $84,558,185 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | $2,337,657 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | $43,890,765 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $114,196,275 | TotalAssetsBOYAmt |
| Total Assets EOY | $148,772,470 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $72,657,460 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $63,342,890 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $41,538,815 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $85,429,580 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | OPERATE A STATE-OF-THE-ART, WORLD CLASS GENOMIC RESEARCH CENTER THAT CREATES AND USES ADVANCED GENOMICS TO UNDERSTAND THE GENETIC BASIS OF DISEASE. FOR MORE INFORMATION, SEE SCHEDULE O. | MissionDesc |
| Significant New Program Srvc | false | SignificantNewProgramSrvcInd |
| Significant Change | Yes (true) | SignificantChangeInd |
| Expense | $38,738,505 | ExpenseAmt |
| Revenue | $9,892,661 | RevenueAmt |
| Desc | RESEARCH NEW YORK GENOME CENTERS (NYGC) RESEARCH SCIENTISTS AND FACULTY ARE EXPLORING GENOMIC CONTRIBUTORS TO HUMAN DISEASE, BOTH IN THEIR OWN PROJECTS AND THROUGH COLLABORATIONS. NYGC RESEARCHERS HAVE PROJECTS UNDERWAY IN CANCER, INCLUDING LUNG, LIVER, BREAST AND MELANOMA AND A LARGE COLLABORATIVE PROJECT IN CANCER IN UNDERSERVED POPULATIONS IN NYC; NEURODEGENERATIVE DISEASES, INCLUDING ALS AND DEMENTIA; AND NEUROPSYCHIATRIC DISEASES, LIKE AUTISM, AMONG OTHERS. OUR BIOINFORMATICS SCIENTISTS PLAY A LEADERSHIP ROLE IN THE COMPLEX ANALYSIS OF DATASETS, INCLUDING INTEGRATING AND HARMONIZING CLINICAL AND GENOMIC DATA NECESSARY FOR ADVANCING RESEARCH. FOR MORE INFORMATION, SEE SCHEDULE O. | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $24,617,085 | ExpenseAmt |
| Grant | $1,300,475 | GrantAmt |
| Revenue | $610,667 | RevenueAmt |
| Desc | RESEARCH SEQUENCING - IN 2018, NYGC SEQUENCED OVER TEN THOUSAND WHOLE GENOME SAMPLES, COMPLETED 639 PROJECTS, AND COLLABORATED WITH 193 INVESTIGATORS FROM 85 INSTITUTIONS WORLDWIDE. AS OF DECEMBER 2018, NYGC HAD 5 ILLUMINA NOVASEQ INSTRUMENTS, 14 ILLUMINA HISEQ X INSTRUMENTS AND 12 ILLUMINA HISEQ 2500 INSTRUMENTS. FOR MORE INFORMATION, SEE SCHEDULE O. | Desc |
Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $4,012,060 | ExpenseAmt |
| Revenue | $2,652,992 | RevenueAmt |
| Desc | CLINICAL SEQUENCING - NYGC IS AUTHORIZED BY THE NEW YORK STATE DEPARTMENT OF HEALTH TO OFFER THE FOLLOWING APPROVED CLINICAL TESTS THROUGH ITS CLEP/CLIA-CERTIFIED CLINICAL LABORATORY: CONSTITUTIONAL WHOLE GENOME SEQUENCING FOR UNDIAGNOSED DISEASE, CONSTITUTIONAL WHOLE GENOME SEQUENCING FOR PREDISPOSITIONAL GENETIC SCREENING, ONCOLOGY WHOLE EXOME AND TRANSCRIPTOME SEQUENCING, CONSTITUTIONAL WHOLE EXOME SEQUENCING, TARGETED SANGER SEQUENCING FOR VARIANT CONFIRMATION, AND SEQUENCING OF PREPARED LIBRARIES FOR MGTL. | Desc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Expenses | $67,367,650 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (true) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (true) | ScheduleBRequiredInd |
| Political Campaign Acty | false | PoliticalCampaignActyInd |
| Lobbying Activities | Yes (true) | LobbyingActivitiesInd |
| Subject To Proxy Tax | false | SubjectToProxyTaxInd |
| Donor Advised Fund | false | DonorAdvisedFundInd |
| Conservation Easements | false | ConservationEasementsInd |
| Collections Of Art | false | CollectionsOfArtInd |
| Credit Counseling | false | CreditCounselingInd |
| Temp Or Permanent Endowments | false | TempOrPermanentEndowmentsInd |
| Report Land Building Equipment | Yes (true) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | false | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | false | ReportProgramRelatedInvstInd |
| Report Other Assets | Yes (true) | ReportOtherAssetsInd |
| Report Other Liabilities | Yes (true) | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | Yes (true) | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | Yes (true) | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | false | ConsolidatedAuditFinclStmtInd |
| School Operating | false | SchoolOperatingInd |
| Foreign Office | Yes (true) | ForeignOfficeInd |
| Foreign Activities | Yes (true) | ForeignActivitiesInd |
| More Than5000 K To Org | false | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | false | MoreThan5000KToIndividualsInd |
| Professional Fundraising | Yes (true) | ProfessionalFundraisingInd |
| Fundraising Activities | false | FundraisingActivitiesInd |
| Gaming Activities | false | GamingActivitiesInd |
| Operate Hospital | false | OperateHospitalInd |
| Grants To Organizations | Yes (true) | GrantsToOrganizationsInd |
| Grants To Individuals | false | GrantsToIndividualsInd |
| Schedule J Required | Yes (true) | ScheduleJRequiredInd |
| Tax Exempt Bonds | false | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | false | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | false | PYExcessBenefitTransInd |
| Loan Outstanding | false | LoanOutstandingInd |
| Grant To Related Person | false | GrantToRelatedPersonInd |
| Business Rln With Org Mem | false | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | false | BusinessRlnWithFamMemInd |
| Business Rln With Officer Ent | false | BusinessRlnWithOfficerEntInd |
| Deductible Non Cash Contri | false | DeductibleNonCashContriInd |
| Deductible Art Contribution | false | DeductibleArtContributionInd |
| Terminate Operations | false | TerminateOperationsInd |
| Partial Liquidation | false | PartialLiquidationInd |
| Disregarded Entity | false | DisregardedEntityInd |
| Related Entity | false | RelatedEntityInd |
| Related Organization Ctrl Ent | false | RelatedOrganizationCtrlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | false | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | false | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (true) | ScheduleORequiredInd |
| IRP Document | 82 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (true) | BackupWthldComplianceInd |
| Employee | 222 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (true) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | Yes (true) | UnrelatedBusIncmOverLimitInd |
| Form990 T Filed | Yes (true) | Form990TFiledInd |
| Foreign Financial Account | false | ForeignFinancialAccountInd |
| Prohibited Tax Shelter Trans | false | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | false | TaxablePartyNotificationInd |
| Nondeductible Contributions | false | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | false | QuidProQuoContributionsInd |
| Form8282 Property Disposed Of | false | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | false | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | false | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | false | IndoorTanningServicesInd |
| Subj To Tax Rmnrtn Ex Prcht Pymt | Yes (true) | SubjToTaxRmnrtnExPrchtPymtInd |
| Subject To Excs Tax Net Invst Inc | false | SubjectToExcsTaxNetInvstIncInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 25 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 23 | IndependentVotingMemberCnt |
| Family Or Business Rln | false | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | false | DelegationOfMgmtDutiesInd |
| Change To Org Documents | false | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | false | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | Yes (true) | MembersOrStockholdersInd |
| Election Of Board Members | Yes (true) | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | Yes (true) | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (true) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (true) | MinutesOfCommitteesInd |
| Officer Mailing Address | false | OfficerMailingAddressInd |
| Local Chapters | false | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (true) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (true) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (true) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (true) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (true) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (true) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (true) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (true) | CompensationProcessOtherInd |
| Investment In Joint Venture | false | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | AL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AK | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CO | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | FL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | GA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | HI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | IL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | LA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | ME | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MD | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MO | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NH | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NJ | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NM | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | ND | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OH | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OK | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | PA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | RI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | SC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | TN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | UT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | VA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WV | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WI | StatesWhereCopyOfReturnIsFldCd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | NANCY KONG | PersonNm |
| Phone | 6469777154 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 101 AVENUE OF THE AMERICAS 7TH FLO | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10013 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part VII | Yes (X) | InfoInScheduleOPartVIIInd |
Form990 Part VII Section A Form990PartVIISectionAGrp (40 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | OfficerOfficerInd | Key EmployeeKeyEmployeeInd | Highest Compensated EmployeeHighestCompensatedEmployeeInd | Former Ofcr Director TrusteeFormerOfcrDirectorTrusteeInd |
|---|---|---|---|---|---|---|---|---|---|---|
| DAFNA BAR-SAGI PHD | ||||||||||
| DIRECTOR | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||||
| RUSSELL L CARSON MBA | ||||||||||
| DIRECTOR & CO-CHAIR | 4.0 | 0.0 | Yes (X) | $0 | $0 | $0 | Yes (X) | |||
| DENNIS S CHARNEY MD | ||||||||||
| DIRECTOR | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||||
| AUGUSTINE MK CHOI MD | ||||||||||
| DIRECTOR | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||||
| NICHOLAS DONOFRIO | ||||||||||
| DIRECTOR | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||||
| JOHN B EHRENKRANZ | ||||||||||
| DIRECTOR | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||||
| ANTHONY B EVNIN PHD | ||||||||||
| DIRECTOR | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||||
| LEE GOLDMAN MD MPH | ||||||||||
| DIRECTOR | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||||
| JOHN HAVENS | ||||||||||
| DIRECTOR | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||||
| WESLIE R JANEWAY | ||||||||||
| DIRECTOR | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||||
| RICHARD P LIFTON MD PHD | ||||||||||
| DIRECTOR | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||||
| EDISON T LIU MD | ||||||||||
| DIRECTOR | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||||
| HERB PARDES MD | ||||||||||
| DIRECTOR & VICE CHAIR | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||||
| FRANK E RICHARDSON MA JD | ||||||||||
| DIRECTOR | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||||
| IVAN G SEIDENBERG MBA | ||||||||||
| DIRECTOR & CO-CHAIR | 4.0 | 0.0 | Yes (X) | $0 | $0 | $0 | Yes (X) | |||
| FRANK V SICA | ||||||||||
| DIRECTOR / COMMITTEE CHAIR | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||||
| JIM SIMONS PHD | ||||||||||
| DIRECTOR | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||||
| STEVEN D SINGER ESQ | ||||||||||
| DIRECTOR | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||||
| ALLEN M SPIEGEL MD | ||||||||||
| DIRECTOR - THRU 07/01/18 | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||||
| SAMUEL L STANLEY JR MD | ||||||||||
| DIRECTOR | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||||
| BRUCE STILLMAN PHD | ||||||||||
| DIRECTOR | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||||
| CRAIG B THOMPSON MD | ||||||||||
| DIRECTOR | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||||
| GORDON F TOMASELLI MD | ||||||||||
| DIRECTOR - START 07/01/18 | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||||
| KEVIN J TRACEY MD | ||||||||||
| DIRECTOR | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||||
| TOM MANIATIS PhD | ||||||||||
| DIRECTOR & NYGC SCI DIR & CEO | 40.0 | 0.0 | Yes (X) | $0 | $0 | $0 | Yes (X) | |||
| CHERYL A MOORE | ||||||||||
| PRESIDENT & COO | 40.0 | 0.0 | Yes (X) | $1,168,254 | $0 | $218,328 | Yes (X) | |||
| CHRIS DUIGNAN | ||||||||||
| VP, FINANCE - THRU 6/30/18 | 40.0 | 0.0 | $338,470 | $0 | $20,819 | Yes (X) | ||||
| ELIZABETH O'BRIEN | ||||||||||
| VICE PRESIDENT & GEN. COUNSEL | 40.0 | 0.0 | $396,814 | $0 | $42,826 | Yes (X) | ||||
| CAROL ASHE | ||||||||||
| CHIEF BUSINESS OFFICER | 40.0 | 0.0 | $434,177 | $0 | $13,867 | Yes (X) | ||||
| KATHLEEN MCGOVERN KEARNS | ||||||||||
| VICE PRESIDENT, DEV'T & COMM | 40.0 | 0.0 | $411,923 | $0 | $29,205 | Yes (X) | ||||
| MATTHEW J PELO - THRU 93018 | ||||||||||
| VP, FINANCIAL STRATEGY & OPS | 40.0 | 0.0 | $276,294 | $0 | $17,615 | Yes (X) | ||||
| SOREN GERMER PhD | ||||||||||
| DIRECTOR SEQUENCING OPERATIONS | 40.0 | 0.0 | $240,138 | $0 | $27,535 | Yes (X) | ||||
| CHARLES GAGNON | ||||||||||
| SENIOR DIR, IT INFRASTRUCTURE | 40.0 | 0.0 | $309,828 | $0 | $38,566 | Yes (X) | ||||
| MICHAEL CHARLES ZODY PHD | ||||||||||
| Bio - Computational Biology | 32.0 | 0.0 | $191,760 | $0 | $17,747 | Yes (X) | ||||
| SHAILAJA GARGEYA | ||||||||||
| SENIOR DIR, SOFTWARE ENGINEER | 40.0 | 0.0 | $306,651 | $0 | $16,878 | Yes (X) | ||||
| DAYNA M OSCHWALD | ||||||||||
| SNR. DIR, INFO. PGM MGMT | 40.0 | 0.0 | $242,184 | $0 | $23,196 | Yes (X) | ||||
| CHRISTOPHER BLACK | ||||||||||
| Director, Research Computing | 40.0 | 0.0 | $198,083 | $0 | $31,237 | Yes (X) | ||||
| PATRICIA KLECANDA | ||||||||||
| DIR, FACILITIES & OFFICE MGMT | 40.0 | 0.0 | $191,540 | $0 | $20,678 | Yes (X) | ||||
| MELISSA PROBER | ||||||||||
| ASSOCIATE COUNSEL | 40.0 | 0.0 | $205,373 | $0 | $8,281 | Yes (X) | ||||
| TOBY BLOOM PHD | ||||||||||
| FORMER KEY EMPLOYEE | 40.0 | 0.0 | $293,830 | $0 | $26,927 | Yes (X) | ||||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $5,205,319 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $0 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $553,705 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 86 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | Yes (true) | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (true) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | false | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (5 entries)
| Address Line1ContractorAddress/USAddress/AddressLine1Txt | CityContractorAddress/USAddress/CityNm | State AbbreviationContractorAddress/USAddress/StateAbbreviationCd | ZIPContractorAddress/USAddress/ZIPCd | ServicesServicesDesc | CompensationCompensationAmt |
|---|---|---|---|---|---|
| Turner construction company | |||||
| 375 Hudson Street | NEW YORK | NY | 10014 | general contractors | $13,969,366 |
| PJ Mechanical Service Maintenan | |||||
| 55 BROAD STREET | NEW YORK | NY | 10004 | Engineering Services | $756,347 |
| Guardian Service Industries Inc | |||||
| 88005 EXPEDITE WAY | CHICAGO | IL | 60695 | CLEANING SERVICES | $444,979 |
| Gensler | |||||
| PO BOX 848279 | DALLAS | TX | 75284 | Architect Services | $397,942 |
| TEC Systems Inc | |||||
| 47-25 34th street 4th Floor | LONG ISLAND CITY | NY | 11101 | Preventative mainten | $300,881 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 16 | CntrctRcvdGreaterThan100KCnt |
| Membership Dues | $2,910,000 | MembershipDuesAmt |
| Government Grants | $30,292,161 | GovernmentGrantsAmt |
| All Other Contributions | $81,836,610 | AllOtherContributionsAmt |
| Total Contributions | $115,038,771 | TotalContributionsAmt |
Program Service Revenue ProgramServiceRevenueGrp (3 entries)
| DescDesc | BusinessBusinessCd | Total Revenue ColumnTotalRevenueColumnAmt | Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt | Unrelated Business RevenueUnrelatedBusinessRevenueAmt |
|---|---|---|---|---|
| RESEARCH | 541700 | $9,892,661 | $5,130,466 | $4,762,195 |
| RESEARCH SEQUENCING | 541700 | $610,667 | $610,667 | |
| CLINICAL SEQUENCING | 541700 | $2,652,992 | $2,652,992 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Revenue | $13,156,320 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $46,088 | TotalRevenueColumnAmt |
| Exclusion | $46,088 | ExclusionAmt |
Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Royalties Revenue RoyaltiesRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $632,326 | TotalRevenueColumnAmt |
| Exclusion | $632,326 | ExclusionAmt |
Gross Rents GrossRentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | $1,412,255 | RealAmt |
Less Rental Expenses LessRentalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | $1,880,695 | RealAmt |
Rental Income Or Loss RentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | -$468,440 | RealAmt |
| Personal | $0 | PersonalAmt |
Net Rental Income Or Loss NetRentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | -$468,440 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $0 | RelatedOrExemptFuncIncomeAmt |
| Exclusion | -$468,440 | ExclusionAmt |
Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $60,768 | SecuritiesAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | -$60,768 | SecuritiesAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | -$60,768 | TotalRevenueColumnAmt |
| Exclusion | -$60,768 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Fundraising Gross Income | $0 | FundraisingGrossIncomeAmt |
| Fundraising Direct Expenses | $0 | FundraisingDirectExpensesAmt |
Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gaming Gross Income | $0 | GamingGrossIncomeAmt |
| Gaming Direct Expenses | $0 | GamingDirectExpensesAmt |
Net Income From Gaming NetIncomeFromGamingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Sales Of Inventory | $0 | GrossSalesOfInventoryAmt |
| Cost Of Goods Sold | $0 | CostOfGoodsSoldAmt |
Net Income Or Loss NetIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Other Revenue Misc OtherRevenueMiscGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | EVENT SPACE REVENUE | Desc |
| Business | 900099 | BusinessCd |
| Total Revenue Column | $104,653 | TotalRevenueColumnAmt |
| Exclusion | $104,653 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Revenue Total | $104,653 | OtherRevenueTotalAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $128,448,950 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $8,394,125 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $4,762,195 | UnrelatedBusinessRevenueAmt |
| Exclusion | $253,859 | ExclusionAmt |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,300,475 | TotalAmt |
| Program Services | $1,300,475 | ProgramServicesAmt |
Grants To Domestic Individuals GrantsToDomesticIndividualsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Foreign Grants ForeignGrantsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Benefits To Members BenefitsToMembersGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $4,194,164 | TotalAmt |
| Program Services | $771,087 | ProgramServicesAmt |
| Management And General | $2,981,950 | ManagementAndGeneralAmt |
| Fundraising | $441,127 | FundraisingAmt |
Comp Disqual Persons CompDisqualPersonsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $18,429,661 | TotalAmt |
| Program Services | $14,633,397 | ProgramServicesAmt |
| Management And General | $3,527,331 | ManagementAndGeneralAmt |
| Fundraising | $268,933 | FundraisingAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,170,963 | TotalAmt |
| Program Services | $675,413 | ProgramServicesAmt |
| Management And General | $459,977 | ManagementAndGeneralAmt |
| Fundraising | $35,573 | FundraisingAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,422,901 | TotalAmt |
| Program Services | $1,862,888 | ProgramServicesAmt |
| Management And General | $514,883 | ManagementAndGeneralAmt |
| Fundraising | $45,130 | FundraisingAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,936,601 | TotalAmt |
| Program Services | $1,491,472 | ProgramServicesAmt |
| Management And General | $410,530 | ManagementAndGeneralAmt |
| Fundraising | $34,599 | FundraisingAmt |
Fees For Services Management FeesForServicesManagementGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $357,511 | TotalAmt |
| Management And General | $357,511 | ManagementAndGeneralAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $150,325 | TotalAmt |
| Management And General | $150,325 | ManagementAndGeneralAmt |
Fees For Services Lobbying FeesForServicesLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $90,000 | TotalAmt |
| Management And General | $90,000 | ManagementAndGeneralAmt |
Fees For Services Prof Fundraising FeesForServicesProfFundraising
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $58,590 | TotalAmt |
| Fundraising | $58,590 | FundraisingAmt |
Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,863,715 | TotalAmt |
| Program Services | $2,286,706 | ProgramServicesAmt |
| Management And General | $577,009 | ManagementAndGeneralAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $347,994 | TotalAmt |
| Program Services | $125,642 | ProgramServicesAmt |
| Management And General | $222,352 | ManagementAndGeneralAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,285,012 | TotalAmt |
| Program Services | $1,935,162 | ProgramServicesAmt |
| Management And General | $347,568 | ManagementAndGeneralAmt |
| Fundraising | $2,282 | FundraisingAmt |
Royalties RoyaltiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $181,510 | TotalAmt |
| Program Services | $181,510 | ProgramServicesAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $14,300,046 | TotalAmt |
| Program Services | $12,488,356 | ProgramServicesAmt |
| Management And General | $1,628,809 | ManagementAndGeneralAmt |
| Fundraising | $182,881 | FundraisingAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $275,449 | TotalAmt |
| Program Services | $251,083 | ProgramServicesAmt |
| Management And General | $22,380 | ManagementAndGeneralAmt |
| Fundraising | $1,986 | FundraisingAmt |
Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $151,765 | TotalAmt |
| Program Services | $60,750 | ProgramServicesAmt |
| Management And General | $80,865 | ManagementAndGeneralAmt |
| Fundraising | $10,150 | FundraisingAmt |
Interest InterestGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,347,709 | TotalAmt |
| Program Services | $1,066,633 | ProgramServicesAmt |
| Management And General | $266,561 | ManagementAndGeneralAmt |
| Fundraising | $14,515 | FundraisingAmt |
Payments To Affiliates PaymentsToAffiliatesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $11,150,729 | TotalAmt |
| Program Services | $10,420,756 | ProgramServicesAmt |
| Management And General | $685,500 | ManagementAndGeneralAmt |
| Fundraising | $44,473 | FundraisingAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $455,990 | TotalAmt |
| Management And General | $455,990 | ManagementAndGeneralAmt |
Other Expenses OtherExpensesGrp (4 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt | Management And GeneralManagementAndGeneralAmt |
|---|---|---|---|
| DIRECT COST OF SEQUENCING | $14,131,349 | $14,131,349 | |
| RESEARCH & CLIA | $2,745,486 | $2,745,486 | |
| RECRUITMENT | $393,981 | $175,991 | $217,990 |
| ALL OTHER EXPENSE | $3,816,259 | $763,494 | $3,052,765 |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $84,558,185 | TotalAmt |
| Program Services | $67,367,650 | ProgramServicesAmt |
| Management And General | $16,050,296 | ManagementAndGeneralAmt |
| Fundraising | $1,140,239 | FundraisingAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part X | Yes (X) | InfoInScheduleOPartXInd |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $6,415,091 | BOYAmt |
| EOY | $7,834,528 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $18,053,451 | BOYAmt |
| EOY | $51,450,236 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $8,882,349 | BOYAmt |
| EOY | $7,070,357 | EOYAmt |
Receivables From Officers Etc ReceivablesFromOfficersEtcGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Inventories For Sale Or Use InventoriesForSaleOrUseGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $4,494,873 | BOYAmt |
| EOY | $3,402,687 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $4,164,286 | BOYAmt |
| EOY | $3,120,795 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $127,685,354 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $62,557,448 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $60,539,957 | BOYAmt |
| EOY | $65,127,906 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Investments Other Securities InvestmentsOtherSecuritiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Investments Program Related InvestmentsProgramRelatedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Intangible Assets IntangibleAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $11,646,268 | BOYAmt |
| EOY | $10,765,961 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $114,196,275 | BOYAmt |
| EOY | $148,772,470 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $9,332,329 | BOYAmt |
| EOY | $11,850,899 | EOYAmt |
Grants Payable GrantsPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Deferred Revenue DeferredRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $4,647,997 | BOYAmt |
| EOY | $5,322,019 | EOYAmt |
Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Escrow Account Liability EscrowAccountLiabilityGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Loans From Officers Directors LoansFromOfficersDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $7,013,580 | BOYAmt |
| EOY | $4,757,610 | EOYAmt |
Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $24,633,098 | BOYAmt |
| EOY | $14,569,000 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $27,030,456 | BOYAmt |
| EOY | $26,843,362 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $72,657,460 | BOYAmt |
| EOY | $63,342,890 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows SFAS117 | Yes (X) | OrganizationFollowsSFAS117Ind |
Unrestricted Net Assets UnrestrictedNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $22,459,118 | BOYAmt |
| EOY | $33,045,706 | EOYAmt |
Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $19,079,697 | BOYAmt |
| EOY | $52,383,874 | EOYAmt |
Permanently Rstr Net Assets PermanentlyRstrNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $41,538,815 | BOYAmt |
| EOY | $85,429,580 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $114,196,275 | BOYAmt |
| EOY | $148,772,470 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Reconcilation Revenue Expnss | $43,890,765 | ReconcilationRevenueExpnssAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | false | AccountantCompileOrReviewInd |
| FS Audited | Yes (true) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Separate Basis Fincl Stmt | Yes (X) | SeparateBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (true) | AuditCommitteeInd |
| Federal Grant Audit Required | Yes (true) | FederalGrantAuditRequiredInd |
| Federal Grant Audit Performed | Yes (true) | FederalGrantAuditPerformedInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Organization170 | Yes (X) | PublicOrganization170Ind |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $52,034,400 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $61,060,764 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $94,901,046 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $70,723,214 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $115,038,771 | CurrentTaxYearAmt |
| Total | $393,758,195 | TotalAmt |
Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $52,034,400 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $61,060,764 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $94,901,046 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $70,723,214 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $115,038,771 | CurrentTaxYearAmt |
| Total | $393,758,195 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Substantial Contributors Tot | $169,097,459 | SubstantialContributorsTotAmt |
| Public Support Total170 | $224,660,736 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $556,550 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $268,801 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $302,728 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $378,725 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $2,090,669 | CurrentTaxYearAmt |
| Total | $3,597,473 | TotalAmt |
Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Other Income170 OtherIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus3 Years | $116,870 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $58,024 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $95,299 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $104,653 | CurrentTaxYearAmt |
| Total | $374,846 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $397,730,514 | TotalSupportAmt |
| Gross Receipts Rltd Activities | $99,394,882 | GrossReceiptsRltdActivitiesAmt |
| Public Support CY170 | 0.56486 | PublicSupportCY170Pct |
| Public Support PY170 | 0.66807 | PublicSupportPY170Pct |
| Thirty Thr Pct Suprt Tests CY170 | Yes (X) | ThirtyThrPctSuprtTestsCY170Ind |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule C IRS990ScheduleC
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Grassroots Lobbying | TotalGrassrootsLobbyingGrp | |
| Total Direct Lobbying | TotalDirectLobbyingGrp | |
| Total Lobbying Expend | TotalLobbyingExpendGrp | |
| Other Exempt Purpose Expend | OtherExemptPurposeExpendGrp | |
| Total Exempt Purpose Expend | TotalExemptPurposeExpendGrp | |
| Lobbying Nontaxable Amount | LobbyingNontaxableAmountGrp | |
| Grassroots Nontaxable | GrassrootsNontaxableGrp | |
| Tot Lbbyng Grassroot Mns Non Tx | TotLbbyngGrassrootMnsNonTxGrp | |
| Tot Lbby Expend Mns Lbbyng Non Tx | TotLbbyExpendMnsLbbyngNonTxGrp | |
| Volunteers | false | VolunteersInd |
| Paid Staff Or Management | Yes (true) | PaidStaffOrManagementInd |
| Media Advertisements | false | MediaAdvertisementsInd |
| Mailings Members | false | MailingsMembersInd |
| Publications Or Broadcast | false | PublicationsOrBroadcastInd |
| Grants Other Organizations | false | GrantsOtherOrganizationsInd |
| Direct Contact Legislators | Yes (true) | DirectContactLegislatorsInd |
| Direct Contact Legislators | $641 | DirectContactLegislatorsAmt |
| Rallies Demonstrations | false | RalliesDemonstrationsInd |
| Other Activities | Yes (true) | OtherActivitiesInd |
| Other Activities | $93,666 | OtherActivitiesAmt |
| Total Lobbying Expenditures | $94,307 | TotalLobbyingExpendituresAmt |
| Not Described Section501c3 | false | NotDescribedSection501c3Ind |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | LOBBYING ACTIVITIES | FormAndLineReferenceDesc |
| Explanation | SCHEDULE C, PART II-B, LINES 1G & 1I THROUGH ITS LEGISLATIVE CONSULTANTS, NYGC ADVOCATES AT THE STATE AND LOCAL LEVEL FOR GOVERNMENT FUNDS TO SUPPORT CURRENT OPERATIONS AND/OR EXPAND RESEARCH OPPORTUNITIES AT NYGC. NYGC ALSO MAINTAINS MEMBERSHIPS IN SEVERAL IRC SECTION 501(C)(6) ORGANIZATIONS THAT REPRESENT THE INTERESTS OF THE MEDICAL RESEARCH COMMUNITY; $3,666 OF THE DUES THAT NYGC PAID TO THESE ASSOCIATIONS WERE ATTRIBUTABLE TO LOBBYING IN 2018. ADDITIONALLY, NYGC STAFF MAY, FROM TIME TO TIME, CONTACT FEDERAL LEGISLATORS OR THEIR STAFF TO ENCOURAGE THEIR SUPPORT FOR MATTERS OF CONCERN TO THE ACADEMIC MEDICAL RESEARCH COMMUNITY. SUCH CONTACT MAY INCLUDE WRITING LETTERS OR OCCASIONAL MEETINGS WITH PUBLIC OFFICIALS. THE APPROXIMATE COST ASSOCIATED WITH NYGC'S COMMUNICATIONS WITH THE FEDERAL GOVERNMENT IN 2018 IS $641. | ExplanationTxt |
Schedule D IRS990ScheduleD
| Field | Value | IRS element (for citing) |
|---|---|---|
| Art Public Exhibition Amounts | ArtPublicExhibitionAmountsGrp | |
| Held Works Art | HeldWorksArtGrp | |
| CY Minus3 Yr Endwmt Fund | CYMinus3YrEndwmtFundGrp | |
| CY Minus4 Yr Endwmt Fund | CYMinus4YrEndwmtFundGrp | |
| Land | LandGrp | |
| Buildings | BuildingsGrp |
Leasehold Improvements LeaseholdImprovementsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $70,585,001 | OtherCostOrOtherBasisAmt |
| Depreciation | $15,148,520 | DepreciationAmt |
| Book Value | $55,436,481 | BookValueAmt |
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $29,920,148 | OtherCostOrOtherBasisAmt |
| Depreciation | $25,892,271 | DepreciationAmt |
| Book Value | $4,027,877 | BookValueAmt |
Other Land Buildings OtherLandBuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $27,180,205 | OtherCostOrOtherBasisAmt |
| Depreciation | $21,516,657 | DepreciationAmt |
| Book Value | $5,663,548 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $65,127,906 | TotalBookValueLandBuildingsAmt |
Other Assets Org OtherAssetsOrgGrp (2 entries)
| DescDesc | Book ValueBookValueAmt |
|---|---|
| SECURITY DEPOSITS | $10,082,135 |
| DEFERRED COMPENSATION | $683,826 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Other Assets | $10,765,961 | TotalBookValueOtherAssetsAmt |
| Federal Income Tax Liability | $0 | FederalIncomeTaxLiabilityAmt |
Other Liabilities Org OtherLiabilitiesOrgGrp (2 entries)
| DescDesc | AmtAmt |
|---|---|
| ACCRUED INTEREST PAYABLE | $27,419 |
| DEFERRED RENT | $26,815,943 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Liability | $26,843,362 | TotalLiabilityAmt |
| Footnote Text | Yes (X) | FootnoteTextInd |
| Total Rev Etc Audited Fincl Stmt | $130,329,645 | TotalRevEtcAuditedFinclStmtAmt |
| Revenue Subtotal | $130,329,645 | RevenueSubtotalAmt |
| Other Revenues Not Included | -$1,880,695 | OtherRevenuesNotIncludedAmt |
| Revenue Not Reported Fincl Stmt | -$1,880,695 | RevenueNotReportedFinclStmtAmt |
| Total Revenue Per Form990 | $128,448,950 | TotalRevenuePerForm990Amt |
| Tot Expns Etc Audited Fincl Stmt | $86,438,880 | TotExpnsEtcAuditedFinclStmtAmt |
| Other Expenses Included | $1,880,695 | OtherExpensesIncludedAmt |
| Expenses Not Reported | $1,880,695 | ExpensesNotReportedAmt |
| Expenses Subtotal | $84,558,185 | ExpensesSubtotalAmt |
| Total Expenses Per Form990 | $84,558,185 | TotalExpensesPerForm990Amt |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| INCOME TAXES | SCHEDULE D, PART X, LINE 2 NYGC IS SUBJECT TO THE PROVISIONS OF THE FASB ASC SECTION 740-10-05, INCOME TAXES-OVERALL, RELATING TO ACCOUNTING AND REPORTING FOR UNCERTAINTY IN INCOME TAXES. NYGC RECOGNIZES THE EFFECT OF INCOME TAX POSITIONS ONLY IF THOSE POSITIONS ARE MORE LIKELY THAN NOT TO BE SUSTAINED AND HAS DETERMINED IT DID NOT HAVE ANY EXPOSURE TO UNCERTAIN TAX POSITIONS DURING 2018 AND 2017. |
| REVENUE AND EXPENSE RECONCILIATION | SCHEDULE D, PART XI, LINE 4B AND PART XII, LINE 2D ($1,880,695) RENTAL EXPENSES ALLOCABLE TO 990, PART VIII |
Schedule F IRS990ScheduleF
Account Activities Outside US AccountActivitiesOutsideUSGrp (4 entries)
| RegionRegionTxt | EmployeeEmployeeCnt | Type Of Activities ConductedTypeOfActivitiesConductedTxt | Specific Services ProvidedSpecificServicesProvidedTxt | Region Total ExpendituresRegionTotalExpendituresAmt |
|---|---|---|---|---|
| Europe (Including Iceland and Greenland) | 9 | Program Services | RESEARCH | $475,888 |
| Middle East and North Africa | 1 | Program Services | RESEARCH | $48,000 |
| North America | 2 | Program Services | RESEARCH | $17,660 |
| East Asia and the Pacific | 1 | Program Services | RESEARCH | $499 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Employees | 13 | SubtotalEmployeesCnt |
| Total Employee | 13 | TotalEmployeeCnt |
| Subtotal Spent | $542,047 | SubtotalSpentAmt |
| Total Spent | $542,047 | TotalSpentAmt |
| Transfer To Foreign Corp | false | TransferToForeignCorpInd |
| Interest In Foreign Trust | false | InterestInForeignTrustInd |
| Foreign Corp Ownership | false | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | false | PassiveForeignInvestmestCoInd |
| Foreign Partnership | false | ForeignPartnershipInd |
| Boycott Countries | false | BoycottCountriesInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | accounting method | FormAndLineReferenceDesc |
| Explanation | SCHEDULE F, PART I, LINE 3 THE PROGRAM EXPENDITURES ARE REPORTED ON THE ACCRUAL METHOD. | ExplanationTxt |
Schedule G IRS990ScheduleG
| Field | Value | IRS element (for citing) |
|---|---|---|
| In Person Solicitations | Yes (X) | InPersonSolicitationsInd |
| Agrmt Prof Fundraising Acty | Yes (true) | AgrmtProfFundraisingActyInd |
Fundraiser Activity Info FundraiserActivityInfoGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | COMMUNITY COUNSELLING SERVICE | PersonNm |
| Activity | CAMPAIGN SERVICES | ActivityTxt |
| Fundraiser Control Of Funds | false | FundraiserControlOfFundsInd |
| Retained By Contractor | $40,000 | RetainedByContractorAmt |
| Net To Organization | -$40,000 | NetToOrganizationAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Retained By Contractors | $40,000 | TotalRetainedByContractorsAmt |
| Total Net To Organization | -$40,000 | TotalNetToOrganizationAmt |
| Licensed States | AL | LicensedStatesCd |
| Licensed States | AK | LicensedStatesCd |
| Licensed States | AR | LicensedStatesCd |
| Licensed States | CA | LicensedStatesCd |
| Licensed States | CO | LicensedStatesCd |
| Licensed States | CT | LicensedStatesCd |
| Licensed States | FL | LicensedStatesCd |
| Licensed States | GA | LicensedStatesCd |
| Licensed States | HI | LicensedStatesCd |
| Licensed States | IL | LicensedStatesCd |
| Licensed States | KS | LicensedStatesCd |
| Licensed States | KY | LicensedStatesCd |
| Licensed States | LA | LicensedStatesCd |
| Licensed States | ME | LicensedStatesCd |
| Licensed States | MD | LicensedStatesCd |
| Licensed States | MA | LicensedStatesCd |
| Licensed States | MI | LicensedStatesCd |
| Licensed States | MN | LicensedStatesCd |
| Licensed States | MS | LicensedStatesCd |
| Licensed States | MO | LicensedStatesCd |
| Licensed States | NH | LicensedStatesCd |
| Licensed States | NJ | LicensedStatesCd |
| Licensed States | NM | LicensedStatesCd |
| Licensed States | NY | LicensedStatesCd |
| Licensed States | NC | LicensedStatesCd |
| Licensed States | ND | LicensedStatesCd |
| Licensed States | OH | LicensedStatesCd |
| Licensed States | OK | LicensedStatesCd |
| Licensed States | OR | LicensedStatesCd |
| Licensed States | PA | LicensedStatesCd |
| Licensed States | RI | LicensedStatesCd |
| Licensed States | SC | LicensedStatesCd |
| Licensed States | TN | LicensedStatesCd |
| Licensed States | UT | LicensedStatesCd |
| Licensed States | VA | LicensedStatesCd |
| Licensed States | WA | LicensedStatesCd |
| Licensed States | WV | LicensedStatesCd |
| Licensed States | WI | LicensedStatesCd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | Schedule G, Part I, Line 2b | FormAndLineReferenceDesc |
| Explanation | COMMUNITY COUNSELLING SERVICE'S ADDRESS: 527 MADISON AVENUE 5TH FLOOR NEW YORK, NY 10022 SCHEDULE G, PART I, LINE 2B, COLUMN (IV) NYGC UTILIZES THE SERVICES OF A FUNDRAISING ADVISOR TO CONSULT ON THE DEVELOPMENT ACTIVITIES OF THE ORGANIZATION. THE ADVISOR OFFERS ADVICE ON STRATEGY AND IS NOT INVOLVED IN DIRECT FUNDRAISING. DUE TO THE NATURE OF THESE ARRANGEMENTS, NYGC IS UNABLE TO REASONABLY DETERMINE THE GROSS RECEIPTS FROM THE FUNDRAISING ACTIVITIES THAT ARE SOLELY ATTRIBUTABLE TO THIS ADVISOR. | ExplanationTxt |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (true) | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (7 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Recipient EINRecipientEIN | IRC SectionIRCSectionDesc | Cash GrantCashGrantAmt | Purpose Of GrantPurposeOfGrantTxt | Address Line2USAddress/AddressLine2Txt |
|---|---|---|---|---|---|---|---|---|
| COLD SPRING HARBOR LABORATORY | ||||||||
| 1 BUNGTOWN RD | COLD SPRING HARBOR | NY | 11724 | 112013303 | 501(C)(3) | $391,342 | RESEARCH SUBAWARD | |
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | ||||||||
| ONE GUSTAVE L LEVY PL | NEW YORK | NY | 10029 | 136171197 | 501(C)(3) | $21,772 | RESEARCH SUBAWARD | BOX 1075 |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA-SF | ||||||||
| 1550 4TH STREET | SAN FRANCISCO | CA | 94158 | 946036493 | CA | $13,839 | RESEARCH SUBAWARD | |
| UNIVERSITY OF WASHINGTON | ||||||||
| 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195 | 916001537 | WA | $213,352 | RESEARCH SUBAWARD | |
| THE ROCKEFELLER UNIVERSITY | ||||||||
| 1230 YORK AVENUE | NEW YORK | NY | 10064 | 131624158 | 501(C)(3) | $271,894 | RESEARCH SUBAWARD | |
| Trustees of Columbia University City of NY | ||||||||
| 630 W 168th Street | New York | NY | 19932 | 135598093 | 501(C)(3) | $285,762 | RESEARCH SUBAWARD | |
| Massachusetts General Hospital | ||||||||
| 55 Fruit Street | Boston | MA | 021142696 | 042697983 | 501(C)(3) | $43,402 | RESEARCH SUBAWARD | |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 7 | Total501c3OrgCnt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | MONITORING USE OF GRANT FUNDS | FormAndLineReferenceDesc |
| Explanation | SCHEDULE I, PART I, LINE 2 NYGC MONITORS SUBRECIPIENTS' USE OF GRANT FUNDS IN BOTH THE PREAWARD AND POST-AWARD STAGES IN COMPLIANCE WITH 2 CFR.200 (UNIFORM GUIDANCE). THIS REVIEW INCLUDES CONDUCTING APPROPRIATE CHECKS FOR SUSPENSION AND DEBARMENT. A SUBRECIPIENT MONITORING FORM IS SENT TO ALL SUB-AWARDEES AND THIS FORM IS THE BASIS BY WHICH NYGC ASSESSES RISK. IN THE POST-AWARD PHASE, NYGC MONITORS PROGRAMMATIC PROGRESS IN A MANNER CONSISTENT WITH THE TERMS AND CONDITIONS OF THE AWARD. NYGC REVIEWS ANY SUBRECIPIENT EXPENSES INVOICED TO NYGC FOR ALLOWABILITY WITH REGARD TO RELEVANT COST PRINCIPLES AND BUDGETARY RESTRICTIONS BEFORE PAYMENT. SUBAWARDS ELIGIBLE FOR FFATA REPORTING ARE RECORDED IN THE FSRS (THE FFATA SUBAWARD REPORTING SYSTEM) IN ACCORDANCE WITH THE FEDERAL REPORTING REQUIREMENTS FOR FIRST TIER SUBAWARDS UNDER NYGC'S PRIME FEDERAL AWARDS. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Idemnification Gross Up Pmts | Yes (X) | IdemnificationGrossUpPmtsInd |
| Housing Allowance Or Residence | Yes (X) | HousingAllowanceOrResidenceInd |
| Written Policy Ref T And E Expnss | Yes (true) | WrittenPolicyRefTAndEExpnssInd |
| Substantiation Required | Yes (true) | SubstantiationRequiredInd |
| Compensation Committee | Yes (X) | CompensationCommitteeInd |
| Independent Consultant | Yes (X) | IndependentConsultantInd |
| Form990 Of Other Organizations | Yes (X) | Form990OfOtherOrganizationsInd |
| Compensation Survey | Yes (X) | CompensationSurveyInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | Yes (true) | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | Yes (true) | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | false | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | false | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | false | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | false | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | false | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | Yes (true) | AnyNonFixedPaymentsInd |
| Initial Contract Exception | false | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (15 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CHERYL A MOORE | ||||||||||||||
| PRESIDENT & COO | $896,170 | $0 | $0 | $0 | $272,084 | $0 | $213,750 | $0 | $4,578 | $0 | $1,386,582 | $0 | $0 | $0 |
| CHRIS DUIGNAN | ||||||||||||||
| VP, FINANCE - THRU 6/30/18 | $159,148 | $0 | $0 | $0 | $179,322 | $0 | $7,608 | $0 | $13,211 | $0 | $359,289 | $0 | $0 | $0 |
| CAROL ASHE | ||||||||||||||
| CHIEF BUSINESS OFFICER | $414,687 | $0 | $0 | $0 | $19,490 | $0 | $13,750 | $0 | $117 | $0 | $448,044 | $0 | $0 | $0 |
| KATHLEEN MCGOVERN KEARNS | ||||||||||||||
| VICE PRESIDENT, DEV'T & COMM | $396,980 | $0 | $0 | $0 | $14,943 | $0 | $10,393 | $0 | $18,812 | $0 | $441,128 | $0 | $0 | $0 |
| TOBY BLOOM PHD | ||||||||||||||
| FORMER KEY EMPLOYEE | $293,830 | $0 | $0 | $0 | $0 | $0 | $7,555 | $0 | $19,372 | $0 | $320,757 | $0 | $0 | $0 |
| MATTHEW J PELO - THRU 93018 | ||||||||||||||
| VP, FINANCIAL STRATEGY & OPS | $244,341 | $0 | $13,083 | $0 | $18,870 | $0 | $11,552 | $0 | $6,063 | $0 | $293,909 | $0 | $0 | $0 |
| ELIZABETH O'BRIEN | ||||||||||||||
| VICE PRESIDENT & GEN. COUNSEL | $381,158 | $0 | $15,656 | $0 | $0 | $0 | $13,750 | $0 | $29,076 | $0 | $439,640 | $0 | $0 | $0 |
| SHAILAJA GARGEYA | ||||||||||||||
| SENIOR DIR, SOFTWARE ENGINEER | $306,651 | $0 | $0 | $0 | $0 | $0 | $12,891 | $0 | $3,987 | $0 | $323,529 | $0 | $0 | $0 |
| DAYNA M OSCHWALD | ||||||||||||||
| SNR. DIR, INFO. PGM MGMT | $236,307 | $0 | $4,750 | $0 | $1,127 | $0 | $7,853 | $0 | $15,343 | $0 | $265,380 | $0 | $0 | $0 |
| SOREN GERMER PhD | ||||||||||||||
| DIRECTOR SEQUENCING OPERATIONS | $222,788 | $0 | $17,350 | $0 | $0 | $0 | $12,191 | $0 | $15,344 | $0 | $267,673 | $0 | $0 | $0 |
| CHRISTOPHER BLACK | ||||||||||||||
| Director, Research Computing | $198,083 | $0 | $0 | $0 | $0 | $0 | $10,198 | $0 | $21,039 | $0 | $229,320 | $0 | $0 | $0 |
| CHARLES GAGNON | ||||||||||||||
| SENIOR DIR, IT INFRASTRUCTURE | $268,518 | $0 | $41,310 | $0 | $0 | $0 | $13,750 | $0 | $24,816 | $0 | $348,394 | $0 | $0 | $0 |
| MICHAEL CHARLES ZODY PHD | ||||||||||||||
| Bio - Computational Biology | $191,760 | $0 | $0 | $0 | $0 | $0 | $9,637 | $0 | $8,110 | $0 | $209,507 | $0 | $0 | $0 |
| PATRICIA KLECANDA | ||||||||||||||
| DIR, FACILITIES & OFFICE MGMT | $191,540 | $0 | $0 | $0 | $0 | $0 | $9,509 | $0 | $11,169 | $0 | $212,218 | $0 | $0 | $0 |
| MELISSA PROBER | ||||||||||||||
| ASSOCIATE COUNSEL | $205,373 | $0 | $0 | $0 | $0 | $0 | $7,704 | $0 | $577 | $0 | $213,654 | $0 | $0 | $0 |
Supplemental Information Detail SupplementalInformationDetail (3 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| SCHEDULE J, PART I, LINE 1 | TAX INDEMNIFICATION AND GROSS-UP PAYMENTS NYGC PAID TAXES ON BEHALF OF ITS PRESIDENT AND COO VIA A PAYROLL TAX GROSS UP FOR LIFE INSURANCE, DISABILITY AND LONG-TERM CARE BENEFITS PURSUANT TO HER OFFER LETTER. AS DESCRIBED BELOW, AN EXECUTIVE COMPENSATION COMMITTEE OF INDEPENDENT BOARD MEMBERS WAS RESPONSIBLE FOR ESTABLISHING HER COMPENSATION PACKAGE, WHICH WAS THEN APPROVED BY THE BOARD OF DIRECTORS. HOUSING ALLOWANCE OR RESIDENCE FOR PERSONAL USE NYGC PROVIDED A HOUSING ALLOWANCE TO THE PRESIDENT AND COO. THE VALUE OF THIS ASSISTANCE WAS TREATED AS TAXABLE COMPENSATION TO THE EMPLOYEE. NYGC SELECTIVELY OFFERS HOUSING ALLOWANCES TO EMPLOYEES, PRINCIPALLY AS A RECRUITING TOOL FOR NEW FACULTY AND POSTDOCTORAL FELLOWS. SUBSIDIZED HOUSING OR HOUSING ALLOWANCES ARE COMMONLY OFFERED BY PEER ACADEMIC INSTITUTIONS IN NEW YORK CITY TO HELP FACULTY AND OTHER RESEARCHERS DEFRAY THE HIGH COST OF HOUSING. |
| EXECUTIVE COMPENSATION | SCHEDULE J, PART I, LINE 3 AT THE TIME OF HIRE, AN AD-HOC EXECUTIVE COMPENSATION COMMITTEE COMPRISED OF INDEPENDENT BOARD MEMBERS (THE "AD-HOC COMMITTEE") WAS RESPONSIBLE FOR ESTABLISHING THE PRESIDENT AND COOS COMPENSATION PACKAGE AND THE TERMS OF HER EMPLOYMENT CONTRACT. HER COMPENSATION WAS DETERMINED THROUGH A REVIEW OF FORM 990 RETURNS AND COMPENSATION INFORMATION FOR TOP MANAGEMENT OFFICIALS AT SIMILARLY SITUATED ORGANIZATIONS OBTAINED THROUGH THE RECRUITING PROCESS. CONSIDERATION ALSO WAS GIVEN TO HER THEN-CURRENT COMPENSATION. ON RECOMMENDATION OF THE AD-HOC COMMITTEE, THE BOARD OF DIRECTORS APPROVED HER COMPENSATION. THIS APPROVAL WAS MEMORIALIZED IN THE BOARD MINUTES. THE "INITIAL CONTRACT" EXCEPTION APPLIED FOR 2016 AND HER COMPENSATION DID NOT CHANGE BETWEEN THE TIME THAT SHE JOINED NYGC AND THE END OF 2018. SEVERANCE PAYMENTS SCHEDULE J, PART I, LINE 4A CHRIS DUIGNAN, FORMER VP, FINANCE - MR. DUIGNAN'S COMPENSATION INCLUDES A SEVERANCE PAYMENT OF $163,020 |
| SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN | SCHEDULE J, PART I, LINE 4B NYGC HAS A DEFERRED COMPENSATION PLAN FOR THE PRESIDENT AND COO. $200,000 WAS DEFERRED IN 2018. NON-FIXED PAYMENTS SCHEDULE J, PART I, LINE 7 THE FOLLOWING INDIVIDUALS RECEIVED DISCRETIONARY BONUSES IN 2018: ELIZABETH O'BRIEN AND MATTHEW J. PELO WHO ARE PART OF NYGC'S SENIOR MANAGEMENT TEAM, AS WELL AS SOREN GERMER, CHARLES GAGNON AND DAYNA M. OSCHWALD. |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (10 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| THE ORGANIZATIONS MISSION | FORM 990, PART I, LINE 1 & PART III, LINE 1: THE NEW YORK GENOME CENTER (NYGC) IS ORGANIZED AND OPERATED AS AN INDEPENDENT, NON-PROFIT CORPORATION, DEDICATED TO STATE-OF-THE-ART, WORLD CLASS GENOMIC RESEARCH, SEQUENCING AND BIOINFORMATICS, WHOSE MEMBERS INCLUDE LEADING ACADEMIC, MEDICAL AND RESEARCH INSTITUTIONS. IT CREATES AND USES ADVANCED GENOMICS TO UNDERSTAND THE GENETIC BASIS OF DISEASE. NYGC HAS THE FOLLOWING KEY OBJECTIVES: (I) FOSTERING INTELLECTUALLY VIBRANT RESEARCH COLLABORATIONS IN THE ACADEMIC AND SCIENTIFIC COMMUNITY IN NEW YORK CITY, ACROSS THE COUNTRY AND AROUND THE WORLD. (II) RECRUITING AND RETAINING WORLD CLASS SCIENTIFIC TALENT TO LEAD THE SCIENTIFIC DEVELOPMENT OF THE ORGANIZATION; (III) SUPPORTING RESEARCH CONDUCTED BY THE INSTITUTIONAL FOUNDING MEMBERS, OTHER ACADEMIC, RESEARCH AND MEDICAL INSTITUTIONS AND THE BIOTECHNOLOGY/PHARMACEUTICAL INDUSTRY TO ADVANCE NYGCS SCIENTIFIC PROGRAM AND GENOMIC RESEARCH; (IV) DEVELOPING ADVANCED BIOINFORMATICS CAPABILITIES BASED UPON THE RESEARCH AND SEQUENCING ACTIVITIES CONDUCTED AT THE ORGANIZATIONS FACILITIES; (V) ADVANCING RESEARCH TO SUPPORT THE DEVELOPMENT OF NEW TREATMENTS, THERAPIES AND THERAPEUTICS TO TREAT HUMAN DISEASE; (VI) PROVIDING TRAINING TO THE ACADEMIC, RESEARCH AND TECHNOLOGY COMMUNITIES; AND (VII) CONDUCTING ACTIVITIES ANCILLARY TO THESE OBJECTIVES. STRATEGIC PLAN FORM 990, PART III, LINE 3: IN THE SUMMER OF 2018, NYGC LEADERSHIP UNDERTOOK A STRATEGIC PLANNING PROCESS TO CONSIDER ITS GROWTH FROM A 'START-UP' GENOME CENTER TO A WORLD-CLASS GENOMIC SCIENCE INSTITUTE. BUILDING ON ITS FOUNDATION, NYGC EMBRACED A NEW SCIENTIFIC DIRECTION, ONE DESIGNED TO POSITION THE ORGANIZATION AT THE FOREFRONT OF DISEASE-BASED GENOMIC RESEARCH, EXPRESSED IN A NEW, FOCUSED MISSION. NYGC'S NEW STRATEGIC DIRECTION LEVERAGES THE STRENGTHS AND CAPABILITIES DEVELOPED SINCE NYGCS FOUNDING, AND ENRICHES ITS LOCAL, NATIONAL, AND INTERNATIONAL COLLABORATIONS. NYGC IS NOW FOCUSING ON RESEARCH IN THREE KEY AREAS WHERE IT CAN MAKE A DIFFERENCE: NEURODEGENERATIVE DISEASES (ALS, ALZHEIMERS, PARKINSONS, HUNTINGTONS); NEUROPSYCHIATRIC DISEASES (AUTISM, SCHIZOPHRENIA, BIPOLAR); AND CANCER THROUGH THE DEVELOPMENT OF NOVEL STATISTICAL METHODS, POPULATION LEVEL ANALYSES, AND APPLICATION OF NOVEL TECHNOLOGIES. THIS STRATEGY NOT ONLY ENABLES DEEP EXPLORATION OF THE GENOMIC UNDERPINNINGS OF THESE DISEASES BUT ALSO DRIVES THE DEVELOPMENT OF INNOVATIVE SEQUENCING AND COMPUTATIONAL METHODS WITH POTENTIAL WIDE-RANGING APPLICATIONS, AND WILL BENEFIT NYGC, ITS MEMBER INSTITUTIONS, AND THE WIDER BIOMEDICAL RESEARCH COMMUNITY. |
| PROGRAM SERVICE ACCOMPLISHMENTS | FORM 990, PART III, LINE 4A, LINE 4B, LINE 4C, LINE 4D: NYGC IS AN INDEPENDENT, NONPROFIT ACADEMIC RESEARCH INSTITUTION WITH THE MISSION OF ADVANCING CLINICAL CARE THROUGH TRANSFORMATIVE GENOMIC RESEARCH. NYGCS WORK BUILDS ON THE STRENGTHS AND CAPABILITIES THAT NYGC HAS DEVELOPED SINCE ITS FOUNDING IN 2010 AND AUGMENTS RESEARCH BEING CONDUCTED BY NYGC MEMBER INSTITUTIONS. COLLABORATING WITH PREMIER ACADEMIC, MEDICAL AND INDUSTRY LEADERS ACROSS THE GLOBE, NYGC IS CONDUCTING DISEASE-BASED GENOMIC RESEARCH IN AREAS WHERE IT HAS DEVELOPED A SIGNIFICANT AND SUCCESSFUL TRACK RECORD, INCLUDING NEURODEGENERATIVE DISEASES SUCH AS ALS, NEUROPSYCHIATRIC DISEASES, PARTICULARLY AUTISM, AND CANCER, FOCUSING ON UNDERSERVED POPULATIONS AND RARE CANCERS, AMONG OTHERS. THROUGH INNOVATIVE RESEARCH AND GENOMIC DISCOVERY, NYGC'S GOAL IS TO ADVANCE HUMAN HEALTH AND THE DEVELOPMENT OF NEW TREATMENTS, THERAPIES AND THERAPEUTICS THAT TREAT DISEASE. NYGC AND ITS MEMBER INSTITUTIONS AND PARTNERS ARE UNITED IN THIS UNPRECEDENTED COLLABORATION OF TECHNOLOGY, SCIENCE AND MEDICINE, DESIGNED TO HARNESS THE POWER OF INNOVATION AND DISCOVERIES TO ADVANCE GENOMIC DISCOVERIES. THEIR SHARED OBJECTIVE IS THE ACCELERATION OF MEDICAL GENOMICS AND PRECISION MEDICINE TO BENEFIT PATIENTS AROUND THE WORLD. NYGC'S INNOVATION, RESEARCH AND QUALITY MAKE IT A UNIQUE AND STRONG COLLABORATIVE PARTNER. IN 2018, NYGC LAUNCHED A NEW STRATEGY THAT LEVERAGES ITS CORE STRENGTHS IN WHOLE GENOME SEQUENCING AND ANALYSIS, SINGLE-CELL TECHNOLOGY AND BIOINFORMATICS. A CRITICAL ELEMENT OF THE NEW SCIENTIFIC MISSION BUILDS ON THE FOUNDATION OF THE COLLABORATIVE RESEARCH PROJECTS AMONG NYGC FACULTY AND STAFF SCIENTISTS WITH MEMBER INSTITUTIONS, AN AFFILIATE MEMBERSHIP PROGRAM, DISEASE- AND TECHNOLOGY-CENTERED WORKING GROUPS AND INDUSTRY PARTNERS. IN 2018, NYGC EXPANDED ITS AFFILIATE MEMBERSHIP PROGRAM, WHICH NOW TOTALS 69 MEMBERS, HAILING FROM 14 ACADEMIC INSTITUTIONS ACROSS THE COUNTRY. RESEARCH AND FACULTY --------------------- SINCE ITS INCEPTION, NYGC HAS ATTRACTED WORLD-CLASS SCIENTISTS WHOSE GENOMIC EXPERTISE - INCLUDING SINGLE CELL GENOMICS, GENOME ENGINEERING, POPULATION AND EVOLUTIONARY GENOMICS, TECHNOLOGY AND METHODS DEVELOPMENT, STATISTICS, COMPUTATIONAL BIOLOGY AND BIOENGINEERING - BRING A MULTIDISCIPLINARY AND IN-DEPTH APPROACH TO THE EVOLVING FIELD OF GENOMICS. NYGC'S FACULTY SUPPORT NYGC'S SCIENTIFIC VISION THROUGH THE ADVANCEMENT OF GENOMIC MEDICINE. FACULTY MEMBERS HAVE JOINT APPOINTMENTS AT THE NYGC'S INSTITUTIONAL FOUNDING MEMBERS TO PROMOTE COLLABORATION, STRENGTHEN RESEARCH CAPABILITIES, ADVANCE ACADEMIC LEADERSHIP, AND ENHANCE ABILITY TO HELP SOLVE HUMAN DISEASES. IN 2018, NYGC MANAGED 35 GRANTS FROM THE NATIONAL INSTITUTES OF HEALTH (NIH). NYGC'S RESEARCHERS ARE WORKING WITH ITS MEMBER INSTITUTIONS AND AN ARRAY OF COLLABORATIVE PARTNERS TO ADDRESS THE FUNDAMENTAL CHALLENGE IN PRECISION MEDICINE: UNDERSTANDING THE RELATIONSHIP BETWEEN DNA SEQUENCE VARIATION AND MECHANISMS FOR HUMAN DISEASES, RANGING FROM CANCER TO AUTISM TO NEURODEGENERATIVE DISEASE. NYGC RESEARCHERS PUBLISHED MORE THAN 50 STUDIES IN LEADING SCIENTIFIC JOURNALS IN 2018, FUELING MOMENTUM FOR IMPORTANT COLLABORATIVE WORK. THEY COMPLETED MORE THAN 639 PROJECTS, COLLABORATING WITH 193 INVESTIGATORS FROM 85 INSTITUTIONS ACROSS THE GLOBE. NYGC FACULTY MEMBERS FOCUS THEIR RESEARCH IN ADVANCED GENOMICS STUDY. WHILE THE FIELD OF SINGLE-CELL SEQUENCING IS RAPIDLY EXPANDING, SIGNIFICANT COMPUTATIONAL CHALLENGES REMAIN, PARTICULARLY WHEN ANALYZING MULTIPLE DATASETS. IN 2018, NYGC CORE FACULTY MEMBER RAHUL SATIJA, PHD, WHO HOLDS A JOINT APPOINTMENT AT NEW YORK UNIVERSITY (NYU), AND HIS LAB MADE ADVANCES IN ADDRESSING THIS CHALLENGE BY DEVELOPING AND DEPLOYING A NEW ALGORITHM THAT ALIGNS MULTIPLE SEQUENCING DATASETS WITH SINGLE-CELL RESOLUTION. THE NEW METHOD HAS IMPLICATIONS FOR BETTER UNDERSTANDING HOW DIFFERENT GROUPS OF CELLS CHANGE DURING DISEASE PROGRESSION, IN RESPONSE TO DRUG TREATMENT, OR ACROSS EVOLUTION. THE TEAMS DESCRIPTION OF THEIR METHOD WAS PUBLISHED IN "NATURE BIOTECHNOLOGY." IN THE FALL OF 2018, THE SATIJA LAB WAS SELECTED TO BE A RECIPIENT OF NIHS FIRST SET OF RESEARCH FUNDING AWARDS FOR THE HUMAN BIOMOLECULAR ATLAS PROGRAM (HUBMAP) TO DEVELOP AN OPEN, GLOBAL FRAMEWORK SUPPORTING EFFORTS TO BUILD A MAP OF CELLS WITHIN THE ADULT HUMAN BODY. THE LABS AWARD-WINNING PROJECT, ENTITLED "COMPREHENSIVE REFERENCE MAP CONSTRUCTION, GEOLOCATION AND DATA INTEGRATION FOR HUBMAP HIVE," ESTABLISHED A NYGC-LED 'MAPPING CENTER' FOR THE HUBMAP CONSORTIUM. WITH THIS AWARD, NYGC BECOMES ONE OF FIVE NIH-DESIGNATED HIVE CENTERS, ALONG WITH THE CARNEGIE MELLON UNIVERSITY, INDIANA UNIVERSITY BLOOMINGTON, HARVARD MEDICAL SCHOOL, AND THE UNIVERSITY OF SOUTH DAKOTA. NYGC CORE FACULTY MEMBER TUULI LAPPALAINEN, PHD, WHO HOLDS A JOINT APPOINTMENT AT COLUMBIA UNIVERSITY, WAS RECIPIENT OF THE 2018 LEENA PELTONEN PRIZE FOR EXCELLENCE IN HUMAN GENETICS IN RECOGNITION OF HER CONTRIBUTIONS TO THE HUMAN GENETICS FIELD. IN FINDINGS PUBLISHED IN "NATURE GENETICS," DR. LAPPALAINEN AND HER RESEARCH TEAM PROVIDED EVIDENCE FOR MODIFIED PENETRANCE, IN WHICH GENETIC VARIANTS THAT REGULATE GENE ACTIVITY MODIFY THE DISEASE RISK CAUSED BY PROTEIN-CODING GENE VARIANTS. THEY ALSO LINKED MODIFIED PENETRANCE TO SPECIFIC DISEASES AT THE GENOME-WIDE LEVEL. THE TEAMS FINDINGS HAVE EXCITING IMPLICATIONS FOR FUTURE PREDICTION OF THE SEVERITY OF SERIOUS DISEASES SUCH AS CANCER AND AUTISM SPECTRUM DISORDER. NYGCS CENTER FOR GENOMICS OF NEURODEGENERATIVE DISEASE'S ALS CONSORTIUM, LED BY HEMALI PHATNANI, PHD., DIRECTOR, CENTER FOR GENOMICS OF NEURODEGENERATIVE DISEASE, HAS GROWN TO 30 MEMBERS IN FIVE COUNTRIES IN JUST A FEW YEARS SINCE ITS INCEPTION. IT SERVES AS AN ORGANIZING HUB OF ALS DATA COLLECTION AND ANALYSIS WITHIN THE RESEARCH COMMUNITY. THE RESULT IS ALS DATA SHARING ON AN UNPARALLELED SCALE EMPOWERING AN INTEGRATED APPROACH TO WORKING TOWARD NEW TREATMENTS AND EFFECTIVE THERAPIES FOR ALS. THROUGH THIS GLOBAL COLLABORATION, CLINICIANS, SCIENTISTS, GENETICISTS, AND COMPUTATIONAL BIOLOGISTS SHARE AN EVER-GROWING RESOURCE OF GENOMIC SEQUENCING AND CLINICAL DATA. BY THE END OF 2018, OVER 3,000 SAMPLES FROM ALS PATIENTS, MORE THAN HALFWAY TO THE GOAL OF 5,000 SAMPLES, HAVE BEEN SEQUENCED AND ANALYZED. THIS DATASET, ONE OF THE LARGEST COHORTS IN THE WORLD, IS AVAILABLE TO RESEARCHERS. |
| CANCER | ------- UTILIZING STATE-OF-THE-ART TECHNOLOGIES AND AN UNPRECEDENTED LEVEL OF COLLABORATION WITH THE LEADING RESEARCH INSTITUTIONS IN NEW YORK, NYGC IS ENGAGED IN MANY CUTTING-EDGE INVESTIGATIONS INTO THE ORIGINS, DIAGNOSIS, AND EVOLUTION OF CANCER. TO ADVANCE COLLABORATIVE EFFORTS ON CANCER GENOMICS, NOBEL LAUREATE HAROLD VARMUS, MD, SENIOR ASSOCIATE CORE MEMBER, NYGC, AND LEWIS THOMAS UNIVERSITY PROFESSOR OF MEDICINE, WEILL CORNELL MEDICINE (WCM), ESTABLISHED THE NEW YORK CANCER GENOMICS RESEARCH NETWORK. IN 2018, DR. VARMUS CONVENED MONTHLY MEETINGS AT NYGC WITH LEADING CANCER RESEARCHERS AND CLINICIANS FROM NYGC'S INSTITUTIONAL FOUNDING MEMBERS AND OTHER KEY ACADEMIC INSTITUTIONS FROM AROUND THE WORLD. THE OBJECTIVE OF THIS MULTIDISCIPLINARY APPROACH IS TO HELP SET CRITICAL PRIORITIES IN TRANSLATING GENOMIC SCIENCE INTO MORE EFFECTIVE TREATMENT OPTIONS FOR ALL CANCER PATIENTS. THE NETWORK INITIATED A CITY-WIDE PROJECT TO ENSURE THAT ADVANCES IN GENOMICS AND PRECISION MEDICINE CAN BE APPLIED TO ALL POPULATIONS AND EXPAND KNOWLEDGE OF THE GENETIC VARIATIONS THAT CONTRIBUTE TO CANCER. NAMED "POLYETHNIC-1000," THE PROJECT UTILIZES THE GREATER NEW YORK AREA'S ETHNIC DIVERSITY TO ADDRESS SEVERAL IMPORTANT SCIENTIFIC QUESTIONS ABOUT THE ROLE OF ETHNICITY IN ONCOLOGY AND OFFER GENOMIC SERVICES DURING THE PROVISION OF CANCER CARE TO ALL POPULATIONS. THIS INITIATIVE INVOLVES PATIENTS AND STAFF AT 16 ACADEMIC HEALTH CENTERS AND PARTNER HOSPITALS IN THE NEW YORK CITY REGION. PHASE ONE, A RETROSPECTIVE STUDY OF 100 SAMPLES FROM COLLABORATING CENTERS, OF THE THREE-PHASE PROJECT BEGAN IN THE LAST QUARTER OF 2018. PHASE TWO, A PROSPECTIVE STUDY, WILL LAUNCH IN MID-2019. NYGC FACULTY ARE WORKING TO ADVANCE GENOMIC INSIGHTS INTO CANCER IN THEIR LABORATORIES. IN 2018, DAN LANDAU, MD, PHD, A NYGC CORE FACULTY MEMBER WHO HOLDS A JOINT APPOINTMENT AT WCM, RECEIVED THE NIH "NEW INNOVATOR" AWARD FOR LIQUID BIOPSY RESEARCH. WITH THE SUPPORT OF THIS PRESTIGIOUS AWARD, DR. LANDAU WILL CONTINUE HIS CRITICAL EFFORTS TO DEVELOP TOOLS FOR LIQUID BIOPSY, THE EARLY-STAGE DETECTION OF CANCER THROUGH THE MEASUREMENT OF TUMOR DNA IN A PATIENT'S BLOOD. DR. LANDAU IS WORKING WITH AN ARRAY OF COLLABORATORS TO GUIDE DRUG COMBINATIONAL THERAPIES AND TEST NEW DRUG TREATMENTS WITH THE AIM OF OPTIMIZING TREATMENT BY CONTINUOUSLY MONITORING GENETIC CHANGES IN CANCER CELLS IN REAL TIME. MARCIN IMIELINSKI, MD, PHD, A NYGC CORE FACULTY MEMBER WHO HOLDS A JOINT APPOINTMENT AT WCM, CONTINUES HIS ILLUMINATING WORK IN IDENTIFYING AND EXPLORING THE GENETIC SIGNATURES THAT SERVE AS BIOMARKERS THAT CAN IMPROVE CANCER DIAGNOSIS AND TREATMENT. WITH STARR CANCER CONSORTIUM SUPPORT, DR. IMIELINSKI SERVES AS CO-PRINCIPAL INVESTIGATOR AND WORK WITH RESEARCHERS FROM WCM AND MEMORIAL SLOAN KETTERING CANCER CENTER (MSKCC) TO EXPLORE THE POTENTIAL OF VARIOUS STRUCTURAL VARIANT MUTATIONAL SIGNATURES AS BIOMARKERS OF CHEMOTHERAPY RESPONSE AND RESISTANCE. NYGC CORE FACULTY MEMBER NEVILLE SANJANA, PHD, WHO HOLDS A JOINT APPOINTMENT AT NYU AND NYU MEDICAL SCHOOL, WROTE THE PRIZE-WINNING ESSAY "A GENOME LABORATORIES TO CATCH AND UNDERSTAND CANCER," WHICH WAS ON THE COVER OF "SCIENCE TRANSLATIONAL MEDICINE." IN 2018, DR. SANJANA WAS SELECTED BY THE AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE (AAAS) FOR ITS PRESTIGIOUS AAAS MARTIN AND ROSE WACHTEL CANCER RESEARCH AWARD. THE AWARD RECOGNIZES AND SUPPORTS DR. SANJANA'S NOVEL USE OF GENE EDITING CALLED "TWO-CELL TYPE" CRISPR TO BETTER UNDERSTAND WHY IMMUNOTHERAPY FAILS IN MOST CANCER PATIENTS. THE GROUNDBREAKING TECHNIQUE IS A SUCCESSFUL MODEL FOR RESEARCHERS TO INTERROGATE OTHER IMMUNE CELL TYPES AND OTHER DISEASE WHERE INTERACTION BETWEEN MULTIPLE CELLS IS IMPORTANT. DR. SANJANA'S FINDINGS COULD HELP CLINICIANS DEVELOP MORE PERSONALIZED TREATMENT TO ACHIEVE BETTER RESPONSE RATES. NYGC'S COMPUTATIONAL BIOLOGY LAB SCIENTISTS CONTRIBUTED THEIR BIOINFORMATICS EXPERTISE TO MANY IMPORTANT SCIENTIFIC PUBLICATIONS IN 2018, INCLUDING THE FOLLOWING CANCER STUDIES: *A COLLABORATION WITH MSKCC, REPORTED IN "PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA," THAT IDENTIFIES ONE WAY THAT LUNG CANCER CELLS OUTSMART DRUGS THAT BLOCK A PROTEIN CALLED EGFR, A COMMON TARGETED DRUG THERAPY. THESE FINDINGS MAY HELP PAVE THE WAY FOR IMPROVED TREATMENTS. *A STUDY LED BY UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER, PUBLISHED IN "GENOME RESEARCH," THAT IDENTIFIES SEVERAL GENETIC MUTATIONS AS DISEASE DRIVERS IN THE SUBSET OF ORAL CANCERS TARGETED BY THE HUMAN PAPILLOMAVIRUS (HPV). RESEARCHERS ANTICIPATE THAT THESE RESULTS WILL FOSTER ADVANCES IN DIAGNOSIS, THERAPY, AND THE GENERAL UNDERSTANDING OF THE ROLE OF HPV IN THE DEVELOPMENT OF ORAL CANCERS. *A COLD SPRING HARBOR LABORATORY-LED ANALYSIS, PUBLISHED IN "CANCER DISCOVERY," THAT COMPARED PATIENT-DERIVED INDIVIDUAL ORGANOIDS - HOLLOW SPHERES OF CELLS CULTURED FROM TUMORS - WITH THEIR ASSOCIATED PRIMARY TUMORS, BY WHOLE-GENOME SEQUENCING AND RNA-SEQUENCING. THE STUDY DETERMINED NOVEL DRIVER MUTATIONS AND GENE SIGNATURES THAT PREDICT SENSITIVITY TO DIFFERENT TYPES OF CHEMOTHERAPIES. THESE FINDINGS WILL HELP FACILITATE PERSONALIZED TREATMENTS FOR PANCREATIC CANCER PATIENTS. |
| NEUROPSYCHIATRIC DISEASES | --------------------------- NYGC IS BUILDING UPON ITS EXPERTISE IN AUTISM GENOMIC RESEARCH TO STUDY A RANGE OF RELATED NEUROPSYCHIATRIC DISORDERS THAT HAVE GENES IMPLICATED IN COMMON, INCLUDING SCHIZOPHRENIA AND BIPOLAR DISEASE. BY YEAR-END 2018, 19,077 WHOLE GENOMES OF AUTISM PATIENTS AND THEIR FAMILIES WERE SEQUENCED BY NYGC. THIS CRITICAL, GROWING DATASET AIDS IN THE ONGOING INVESTIGATIONS OF NYGC FACULTY AND STAFF SCIENTISTS, MEMBER INSTITUTIONS, AND OTHER COLLABORATIVE PARTNERS. THIS WORK IS PART OF A FOUR-YEAR GRANT OF $40 MILLION FROM THE NATIONAL HUMAN GENOME RESEARCH INSTITUTE, A DIVISION OF THE NATIONAL INSTITUTES OF HEALTH, WHICH WAS AWARDED TO NYGC IN 2015 TO CREATE A CENTER FOR COMMON DISEASE GENOMICS. THIS COLLABORATIVE LARGE-SCALE GENOME SEQUENCING PROGRAM IS FOCUSED ON ADVANCING UNDERSTANDING OF AUTISM. NYGC'S FACULTY ARE ALSO ENGAGED IN THIS WORK. DR. SANJANA RECEIVED THE YOUNG INVESTIGATOR AWARD AND LEICHTUNG FAMILY INVESTIGATOR DESIGNATION FROM THE BRAIN & BEHAVIOR RESEARCH FOUNDATION IN 2018. THIS AWARD SUPPORTS DR. SANJANA'S "HUMAN NEURONS IN A DISH" APPROACH OF USING CRISPR GENE-EDITING GUIDE RNA LIBRARIES TO IDENTIFY CHANGES IN NEURONAL GENE EXPRESSION, WITH THE GOAL OF HELPING TO DESIGN AND IMPROVE THERAPIES. DR. SANJANA EARNED AN ADDITIONAL HONOR BY BEING SELECTED FOR THE FOUNDATION'S RESEARCH PARTNERS PROGRAM AS A LEICHTUNG FAMILY INVESTIGATOR. DR. SANJANA WAS ALSO JOINT LEAD RESEARCHER WITH INVESTIGATORS FROM BOSTON CHILDREN'S HOSPITAL ON A STUDY OF THREE CHILDREN FROM TWO UNRELATED FAMILIES THAT ADVANCED UNDERSTANDING OF RARE VARIANTS IN THE AUTISM SPECTRUM DISORDER KNOWN AS ANGELMAN SYNDROME. THE TEAM'S REPORT WAS PUBLISHED IN 2018 BY "THE AMERICAN JOURNAL OF MEDICAL GENETICS." TECHNOLOGY INNOVATION --------------------- TODAY, THERE ARE NUMEROUS EXCITING CLINICAL USES FOR GENOMIC INFORMATION, YET SUCH INFORMATION HAS TO BE GENERATED AND INTERPRETED IN A TIMELY, SCALABLE, AND HIGH-QUALITY FASHION IN ORDER TO SPEED AND IMPROVE THE DELIVERY OF RESULTS TO RESEARCHERS AND CLINICIANS. NYGC'S TECHNOLOGY INNOVATION LABORATORY IS A CREATIVE, MULTIDISCIPLINARY HUB WHERE SCIENTISTS ARE DEVELOPING AND DEPLOYING NEXT-GENERATION SEQUENCING METHODS, TECHNOLOGIES AND TOOLS THAT LEAD TO SCIENTIFIC ADVANCES AND NEW INSIGHTS AND THERAPIES FOR PATIENTS. THE TECHNOLOGY INNOVATION LABORATORY IS DEDICATED TO GENERATING NEW TECHNOLOGIES, PROTOCOL DEVELOPMENT, EQUIPMENT EVALUATION, AND INFORMATICS TOOL DEVELOPMENT/INTEGRATION. NYGC SCIENTISTS ARE DEVELOPING VARIOUS NOVEL TECHNOLOGIES TO SPEED UP, REDUCE COSTS OF AND DECREASE THE HANDLING OF NEXT-GENERATION LIBRARY PREPARATION REACTIONS OF NEXT-GENERATION LIBRARY PREPARATION REACTIONS. RESEARCH SEQUENCING ------------------- NYGC HAS ONE OF THE LARGEST VOLUME WHOLE GENOME SEQUENCING PROGRAMS IN NEW YORK. IN THE PAST FIVE YEARS, NYGC'S SEQUENCING LABORATORY HAS SEQUENCED TENS OF THOUSANDS OF WHOLE GENOME SAMPLES. IN 2018, THE CENTER ACQUIRED NOVASEQ SYSTEMS SEQUENCERS TO SUPPLEMENT ITS STABLE OF HISEQ X AND 2500 SEQUENCERS. THIS STATE-OF-THE-ART SEQUENCING TECHNOLOGY ENABLES NYGC TO CONDUCT LARGE-SCALE GENOMICS PROJECTS WITH GREATER SPEED AND SAMPLE VOLUMES, AND TO EXPLORE THE GENOME IN MORE DEPTH WITH GREATER EFFICIENCY. NYGCS RESEARCH SEQUENCING LAB, LED BY SOREN GERMER, PHD, SENIOR SCIENTIFIC DIRECTOR, SEQUENCING OPERATIONS (WHO BECAME SENIOR VICE PRESIDENT OF GENOME TECHNOLOGIES IN JANUARY 2019), OPTIMIZED A POOLING AND LOADING SCHEME FOR WHOLE GENOME SEQUENCING ON NOVASEQ SEQUENCERS THAT MAXIMIZES THE NUMBER OF SAMPLES SEQUENCED PER RUN AND REDUCES REAGENT COSTS PER SAMPLE. THE LAB ALSO DEVELOPED A NEW WHOLE GENOME BISULFITE SEQUENCING METHOD IN COLLABORATION WITH THE ALBERT EINSTEIN COLLEGE OF MEDICINE. THIS NEW METHOD IMPROVES THE EFFICIENCY AND COST OF BISULFITE CONVERSION OF DNA, A STANDARD APPROACH TO STUDY DNA METHYLATION, A FORM OF DNA MODIFICATION THAT PLAYS AN IMPORTANT ROLE IN AN ARRAY OF BIOLOGICAL PROCESSES. THE TEAMS DESCRIPTION OF THE METHOD WAS PUBLISHED IN "GENOME RESEARCH" IN 2018. |
| EDUCATION | ----------- AS PART OF NYGC'S EDUCATIONAL MISSION, IT HOSTED MANY SCIENTIFIC MEETINGS, WORKSHOPS, CONFERENCES AND LECTURES IN 2018. THE NYGC GENOME CENTER CANCER GROUP ORGANIZES THE NEW YORK CANCER GENOMICS RESEARCH NETWORK MEETINGS THAT ARE HELD ON THE FIRST TUESDAY OF EVERY MONTH DURING THE ACADEMIC YEAR, BRINGING TOGETHER LEADING RESEARCHERS AND CLINICIANS FROM NYGC MEMBER AND OTHER KEY ACADEMIC INSTITUTIONS. THE MEETINGS ARE INTENDED PRIMARILY FOR PRINCIPAL INVESTIGATORS AND THEIR TRAINEES IN THE NEW YORK REGION. NYGC HELD "EVENING TALKS," A LECTURE SERIES FOR THE GENERAL PUBLIC ON ADVANCES IN GENOMIC SCIENCE, SPONSORED BY THE NEW YORK CITY COMMUNITY TRUST-PYEWACKET FUND. THESE TALKS ARE DESIGNED TO MAKE THE LATEST GENOMIC RESEARCH DISCOVERIES MORE ACCESSIBLE AND UNDERSTANDABLE FOR THE GENERAL PUBLIC. THESE WELL-ATTENDED LECTURES (AVERAGING 150 GUESTS PER EVENT) FEATURE PANELS OF LEADING RESEARCHERS AND CLINICIANS FROM NYGC AND/OR MEMBER INSTITUTIONS. IN 2018, NYGC HELD TALKS ON RARE DISEASE GENOMICS, THE LATEST ADVANCES IN DNA ANALYSIS, AND SPACE GENOMICS. NYGC HOSTED "FIVE POINTS" LECTURES FOR THE SCIENTIFIC COMMUNITY, FEATURING LEADING RESEARCHERS FROM AROUND THE COUNTRY AND ABROAD. THESE LECTURES BRING LEADING SCIENTISTS TO NYGC FOR IN-DEPTH DISCUSSIONS OF THEIR WORK WITH RESEARCHERS, CLINICIANS, AND STUDENTS FROM NYGC, ITS MEMBER INSTITUTIONS, AND OTHERS IN THE SCIENTIFIC COMMUNITY. IN FALL 2018, NYGC HOSTED ITS SECOND "GENOMIC INNOVATION" COURSE, A 14-WEEK PROJECT-FOCUSED COURSE DEVELOPED BY NYGC CORE FACULTY MEMBERS NEVILLE SANJANA, PHD AND TUULI LAPPALAINEN, PHD. THE FOUR-CREDIT CLASS, THE FIRST-EVER GRADUATE-LEVEL COURSE TO BE HOSTED BY NYGC, INTRODUCED STUDENTS TO CUTTING-EDGE TECHNOLOGIES AND APPLICATIONS IN GENETICS AND GENOMICS AND THEIR RESPONSIBLE USE IN SCIENCE AND SOCIETY. GRADUATE STUDENTS FROM COLD SPRING HARBOR LABORATORY, COLUMBIA UNIVERSITY, ALBERT EINSTEIN COLLEGE OF MEDICINE, MOUNT SINAI SCHOOL OF MEDICINE (MSSM) MSKCC, NYU, THE ROCKEFELLER UNIVERSITY, STONY BROOK UNIVERSITY AND WCM COULD RECEIVE CREDIT FOR THE CLASS THROUGH THEIR REGISTRAR'S OFFICE AND THE COURSE WAS OFFICIALLY LISTED IN THE COURSE CATALOGS OF COLUMBIA, NYU, AND EINSTEIN. THE FIRST CLASS INCLUDED STUDENTS FROM COLUMBIA, EINSTEIN, MSKCC, NYU, MSSM AND WCM. NYGC HELD ITS 4TH SEQUENCING INFORMATICS WORKSHOP IN NOVEMBER 2018. THE WEEK-LONG EVENT CONSISTED OF LECTURES FROM NYGCS BIOINFORMATICS TEAM AND HANDS-ON EXERCISES. STUDENTS WERE INTRODUCED TO A VARIETY OF SEQUENCING INFORMATICS TOPICS, INCLUDING SEQUENCING EXPERIMENT DESIGN CONSIDERATIONS, STANDARD DATA VISUALIZATION TECHNIQUES, RNA-SEQ DATA ANALYSIS AND STRUCTURAL VARIATION CALLING. JLABS PARTNERSHIP ------------------ IN JUNE 2018, NYGC, JOHNSON & JOHNSON INNOVATION LLC AND NEW YORK STATE CELEBRATED THE OPENING OF JLABS @ NYC, A NEW 30,000 SQUARE-FOOT FACILITY ON THE NYGC'S THIRD FLOOR THAT IS HOME TO 28 LIFE SCIENCE STARTUPS IN THE BIOTECH, PHARMACEUTICAL, MEDICAL DEVICE AND CONSUMER AND HEALTH TECH SECTORS. THE INITIATIVE SUPPORTS THE GROWTH OF HEALTH CARE SOLUTIONS IN THE REGION BY PROVIDING A COMPREHENSIVE COMMERCIALIZATION VEHICLE FOR EMERGING LIFE SCIENCE COMPANIES. JLABS' SUPPORT OF TALENTED SCIENTISTS IN NYC AS THEY TAKE THEIR INNOVATIVE IDEAS TO MARKET ALIGNS WITH NYGC'S MISSION OF FOSTERING INTELLECTUALLY VIBRANT COLLABORATIONS THAT ADVANCE THE DEVELOPMENT OF NEW TREATMENTS, THERAPIES AND THERAPEUTICS AGAINST HUMAN DISEASE. ORGANIZATION MEMBERS FORM 990, PART VI, SECTION A, LINE 6: AS OF DECEMBER 31, 2018, THE CENTER HAD A TOTAL OF 17 MEMBERS, CONSISTING OF 12 INSTITUTIONAL FOUNDING MEMBERS AND FIVE ASSOCIATE MEMBERS. *THE INSTITUTIONAL FOUNDING MEMBERS ARE THE FOLLOWING RECOGNIZED ACADEMIC, MEDICAL AND RESEARCH INSTITUTIONS: (1) COLD SPRING HARBOR LABORATORY, (2) CORNELL UNIVERSITY/WEILL CORNELL MEDICINE, (3) THE JACKSON LABORATORY, (4) MEMORIAL SLOAN-KETTERING CANCER CENTER, (5) ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, (6) NEW YORK-PRESBYTERIAN HOSPITAL, (7) NEW YORK UNIVERSITY, SCHOOL OF MEDICINE, (8) NORTHWELL HEALTH, (9) THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK, ON BEHALF OF STONY BROOK UNIVERSITY, (10) THE ROCKEFELLER UNIVERSITY, (11) THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, AND (12) ALBERT EINSTEIN COLLEGE OF MEDICINE. *ASSOCIATE MEMBERS: (1) AMERICAN MUSEUM OF NATURAL HISTORY, (2) HOSPITAL FOR SPECIAL SURGERY, (3) THE NEW YORK STEM CELL FOUNDATION, (4) ROSWELL PARK CANCER INSTITUTE; AND (5) PRINCETON UNIVERSITY |
| ORGANIZATION MEMBERS - DECISION MAKING | FORM 990, PART VI, SECTION A, LINE 7A & 7B: EACH INSTITUTIONAL FOUNDING MEMBER APPOINTS ONE REPRESENTATIVE TO SERVE ON NYGCS BOARD OF DIRECTORS. THE BOARD OF DIRECTORS ALSO INCLUDES THE SCIENTIFIC DIRECTOR AND OTHER DESIGNATED DIRECTORS OR INDIVIDUALS APPOINTED BY THE BOARD. DECISIONS REQUIRING BOARD APPROVAL INCLUDE THE ADMISSION OF NEW MEMBERS, CHANGES TO THE MISSION, CERTIFICATE OF INCORPORATION, AND BYLAWS, APPOINTMENT OR REMOVAL OF THE CHAIRPERSON OF THE BOARD AND THE SCIENTIFIC DIRECTOR, AND ADOPTION OF CERTAIN POLICIES AND PROCEDURES. THE BOARD ALSO REVIEWS AND APPROVES THE ANNUAL OPERATING BUDGET. MANAGEMENT HAS THE ABILITY TO ENTER INTO BUSINESS ARRANGEMENTS AND CONTRACTS, INCLUDING FINANCING ARRANGEMENTS. |
| FORM 990 REVIEW | FORM 990, PART VI, SECTION B, LINE 11: THE FORM 990 IS PREPARED BY AN INDEPENDENT PUBLIC ACCOUNTING FIRM, UTILIZING INFORMATION PROVIDED BY MANAGEMENT. UPON RECEIPT OF THE DRAFT FORM 990, MANAGEMENT, INCLUDING THE SENIOR VICE PRESIDENT, FINANCE & ADMINISTRATION; DIRECTOR OF FINANCE; GENERAL COUNSEL; AND PRESIDENT & COO, REVIEW THE FORM. PRIOR TO FILING, MANAGEMENT PRESENTS THE FORM 990 TO THE AUDIT COMMITTEE OF THE BOARD FOR REVIEW AND COMMENT. ALSO PRIOR TO FILING, MANAGEMENT PROVIDES THE FORM 990 TO THE ENTIRE BOARD OF DIRECTORS. |
| CONFLICT OF INTEREST POLICY & REVIEW | FORM 990, PART VI, SECTION B, LINE 12C: NYGC REQUIRES ALL INTERESTED PERSONS (DEFINED AS BOARD MEMBERS, PRINCIPAL OFFICERS, OR MEMBERS OF A COMMITTEE TO WHICH THE BOARD HAS DELEGATED POWERS) TO DISCLOSE CONFLICTS OF INTEREST AS REQUIRED BY THE CONFLICT OF INTEREST POLICY. NYGC FOLLOWS A PROCEDURE FOR OBTAINING SUCH DISCLOSURES ANNUALLY. ANY POTENTIAL CONFLICTS OF INTEREST MUST BE REVIEWED BY THE BOARD. IF AN INTERESTED PERSON HAS A POTENTIAL CONFLICT OF INTEREST, HE OR SHE MAY MAKE A PRESENTATION AT THE BOARD OR COMMITTEE MEETING, BUT AFTER SUCH PRESENTATION, HE/SHE SHALL LEAVE THE MEETING DURING THE DISCUSSION OF, AND THE VOTE ON, THE TRANSACTION OR ARRANGEMENT THAT CREATES THE POTENTIAL CONFLICT OF INTEREST. |
| COMPENSATION REVIEW AND APPROVAL | FORM 990, PART VI, SECTION B, LINE 15: FOR THE ORGANIZATIONS TOP MANAGEMENT OFFICIAL, PLEASE REFER TO SCHEDULE J NARRATIVES FOR THE PROCESS OF DETERMINING COMPENSATION. NYGC HIRED AN INDEPENDENT COMPENSATION CONSULTANT IN LATE 2016 TO REVIEW SENIOR MANAGEMENT'S COMPENSATION. RESULTS OF THIS REVIEW WERE PROVIDED TO THE AD-HOC COMPENSATION COMMITTEE IN EARLY 2017. THE REVIEW SHOWED THAT THE COMPENSATION PAID TO ALL MEMBERS OF SENIOR MANAGEMENT (CHERYL MOORE, CAROL ASHE, CHRISTOPHER DUIGNAN, KATHLEEN MCGOVERN KEARNS, ELIZABETH O'BRIEN, AND MATTHEW PELO) WAS REASONABLE. THE AD-HOC COMPENSATION COMMITTEE MET AGAIN IN DECEMBER 2017 AND DISCUSSED SENIOR MANAGEMENT COMPENSATION. SENIOR MANAGEMENT DID NOT RECEIVE MERIT INCREASES IN 2018. TWO MEMBERS OF SENIOR MANAGEMENT RECEIVED DISCRETIONARY BONUSES IN 2018 (ELIZABETH O'BRIEN AND MATTHEW PELO), WHICH WERE APPROVED BY THE AD-HOC COMPENSATION COMMITTEE IN DECEMBER 2017. THE PRESIDENT & COO DECLINED A MERIT INCREASE AND HER COMPENSATION WAS UNCHANGED. |
| DOCUMENT DISCLOSURE | FORM 990, PART VI, SECTION C, LINE 19: NYGC'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST. COMPENSATION OF OFFICERS AND DIRECTORS FORM 990, PART VII, SECTION A IN 2018, TOM MANIATIS, PHD., WAS EMPLOYED BY AN UNRELATED ENTITY AND CONTRIBUTED 15% OF HIS TIME TO WORK ON A NATIONAL INSTITUTES OF HEALTH GRANT AWARDED TO NYGC TO CREATE A CENTER FOR COMMON DISEASE GENOMICS. INDEPENDENT CONTRACTORS FORM 990, PART VII, SECTION B NYGC was reimbursed by either a grant from the New York State Urban Development Corporation (Empire State Development) or J&J Services (J&J) for nearly all of the vendor compensation described in part vii because the services conducted by the vendors related to JLABS (see Form 990, Schedule O at page 68 for JLABS description). -Turner Construction Company was the general contractor for the JLABS buildout. All of the compensation listed in part vii was reimbursed by the Empire State Development grant. -Gensler was the architect for the JLABS buildout. All of the compensation listed in part vii was reimbursed by the Empire State Development grant. -P.J. Mechanical Service & Maintenance Co. provided engineering services to NYGC and JLABS. A portion of the compensation listed in part vii related to services performed for JLABS was reimbursed to NYGC by either J&J or the Empire State Development grant. -Guardian Services Industries provided cleaning services to NYGC and JLABS. A portion of the compensation listed in part vii related to services performed for JLABS was reimbursed to NYGC by J&J. -T.E.C. Systems Inc. provided preventative maintenance services to NYGC and JLABS. A portion of the compensation listed in part vii related to services performed for JLABS was reimbursed to NYGC by either J&J or the Empire State Development grant. NET ASSET CLASSIFICATION FORM 990, PART X, LINES 27-29: THE FASB ISSUED ACCOUNTING STANDARDS UPDATE (ASU) 2016-14 NOT-FOR-PROFIT ENTITIES (TOPIC 958), PRESENTATION OF FINANCIAL STATEMENTS OF NOT-FOR-PROFIT ENTITIES, WHICH AMONG OTHER THINGS, CHANGES HOW NOT-FOR-PROFIT ENTITIES REPORT NET ASSET CLASSES. THE SIGNIFICANT REQUIREMENTS OF ASU 2016-14 INCLUDE REDUCTION IN THE NUMBER OF NET ASSET CLASSES FROM THREE TO TWO: WITH DONOR RESTRICTIONS (FORMERLY REPORTED AS TEMPORARILY RESTRICTED NET ASSETS) AND WITHOUT DONOR RESTRICTIONS (FORMERLY REPORTED AS UNRESTRICTED NET ASSETS). THE 2018 FORM 990, PART X WAS NOT UPDATED TO REFLECT THE CHANGE IN NET ASSET CLASS TERMINOLOGY; THEREFORE, NYGC HAS REPORTED NET ASSETS WITHOUT DONOR RESTRICTION AS UNRESTRICTED NET ASSETS AND NET ASSETS WITH DONOR RESTRICTIONS AS TEMPORARILY RESTRICTED NET ASSETS. |